ICRF-193, CAS [[21416-88-6]]

Produktübersicht

• Artikelname: ICRF-193, CAS [[21416-88-6]]
• Artikelnummer: MCE-HY-118590
• Hersteller Artikelnummer: HY-118590
• Alternativnummer: MCE-HY-118590-5MG,MCE-HY-118590-50MG,MCE-HY-118590-10MG,MCE-HY-118590-1MG,MCE-HY-118590-25MG,MCE-HY-118590-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

ICRF-193 is a DNA Topoisomerase II inhibitor. (S,S)- and (R,R)-isomers ICRF-193 make up an racemic mixture, ICRF-196 (HY-118590A). ICRF-193 can inhibit DNA syntheses and induces apoptosis. ICRF-193 exhibits anti-cancer and anti-inflammation effects. ICRF-193 shows cardioprotective effect against anthracycline toxicity to cardiomyocytes. ICRF-193 can be used for the researches of cancer, infection, inflammation and cardiovascular disease, such as acute promyelocytic leukemia[1][2][3][4][5][6].

Produkteigenschaften

• Molekulargewicht: 282.30
• Reinheit: 99.64
• CAS Nummer: [21416-88-6]
• Formel: C12H18N4O4
• Target-Kategorie: Apoptosis,DNA/RNA Synthesis,Fungal,Topoisomerase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound